E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/12/2019 in the Prospect News Structured Products Daily.

New Issue: RBC sells $100,000 contingent coupon barrier autocalls tied to three ETFs

By Sarah Lizee

Olympia, Wash., Nov. 12 – Royal Bank of Canada priced $100,000 of autocallable contingent coupon barrier notes due Nov. 9, 2021 linked to the least performing of the SPDR S&P Bank ETF, the SPDR S&P Biotech ETF and the Technology Select Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.

Each quarter, the notes pay a contingent coupon at an annual rate of 14.4% if each ETF closes at or above its trigger level, 70% of its initial share price, on the observation date for that quarter.

The notes will be called at par if each ETF closes at or above its initial share price on any quarterly observation date.

The payout at maturity will be par unless any ETF finishes below its trigger level, in which case investors will be exposed to the decline of the least-performing ETF from its initial share price.

RBC Capital Markets, LLC is the underwriter.

Issuer:Royal Bank of Canada
Issue:Autocallable contingent coupon barrier notes
Underlying ETFs:SPDR S&P Bank ETF, the SPDR S&P Biotech ETF and the Technology Select Sector SPDR fund
Amount:$100,000
Maturity:Nov. 9, 2021
Coupon:14.4% per year, payable quarterly if each ETF closes at or above trigger level on observation date for that quarter
Price:Par
Payout at maturity:Par unless any ETF finishes below trigger level, in which case full exposure to decline of least-performing ETF from initial share price
Call:At par if each ETF closes at or above initial share price on any quarterly observation date
Initial share prices:$45.84 for bank ETF, $83.14 for biotech ETF, $85.11 for tech ETF
Trigger levels:$32.09 for bank ETF, $58.20 for biotech ETF, $59.58 for tech ETF; 70% of initial share prices
Pricing date:Nov. 4
Settlement date:Nov. 12
Underwriter:RBC Capital Markets, LLC
Fees:0.5%
Cusip:78015KDL5

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.